A Study to Assess Bioavailability and Pharmacokinetics of CAT- 354

Study identifier:CAT-354-0703

ClinicalTrials.gov identifier:NCT00638989

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Open-Label, Parallel-Group, Bioavailability Study to Assess the Pharmacokinetics of CAT-354 Following Subcutaneous and Intravenous Administration

Medical condition

asthma, Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

-

Sex

Male

Actual Enrollment

30

Study type

Interventional

Age

19 Years - 55 Years

Date

Study Start Date: 11 Apr 2008
Primary Completion Date: 07 Jun 2008
Study Completion Date: 07 Jun 2008

Study design

Allocation: Randomized
Endpoint Classification: Pharmacokinetics/dynamics Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Mar 2017 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

-

Inclusion and exclusion criteria